Developer docs
API playgroundTry for free, no card

Search company profiles

Technopath Clinical Diagnostics

Full company profile

uuid000dpzj

Namestring
Technopath Clinical Diagnostics
Legal namestring
Technopath Clinical Diagnostics
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Technopath Clinical Diagnostics is an Ireland-based developer and manufacturer of third-party quality control (QC) materials and informatics software for clinical laboratories, operating as a subsidiary of LGC Clinical Diagnostics within the London-listed LGC Group. The company's core technology comprises Multichem® QC materials in a proprietary frozen liquid stable, ready-to-use vial format spanning clinical chemistry, immunoassay, cardiac markers (including High Sensitive Troponin), infectious disease, immunology, urine chemistry, diabetes, fertility, immunosuppressant drugs, coagulation, mass spectrometry, and COVID-19 testing applications. Its IAMQC® software platform — including IAMQC Peer for cross-laboratory peer comparison reporting and IAMQC Infinity for next-generation QC data management — provides subscription-based automated quality control monitoring and reporting.

The company serves hospital laboratories, reference laboratories, and commercial clinical testing facilities globally, with reference customers including Northwell Health (USA), PathCare (South Africa), and Ramon y Cajal Hospital (Spain). Technopath generates revenue through three streams: consumable QC material sales (recurring volume), IAMQC software subscriptions, and IVD raw materials supply to IVD manufacturers. Its go-to-market combines enterprise field sales targeting major laboratories and healthcare systems with a global distribution partnership with Abbott Diagnostics Division established in 2012, under which Technopath holds exclusive status as the only Abbott-approved onboard third-party QC provider for Alinity ci systems. Products meet CLIA, CLSI, CAP, RiliBÄK, and ISO accreditation requirements, addressing regulatory compliance, cost efficiency, and automated monitoring pain points for clinical laboratories.

Short descriptiontext

Technopath Clinical Diagnostics, an Ireland-based LGC Group subsidiary, develops and manufactures Multichem third-party quality control materials and IAMQC informatics software for clinical laboratories worldwide, distributed globally through Abbott Diagnostics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBallina, Ireland
HQ citystring
Ballina
HQ countrystring
Ireland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical quality controls, third party QC materials, laboratory informatics software, in vitro diagnostics controls, immunoassay quality controls
Industry3 codes
PRIMARYHLAHAAAL
Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHAAAO
Laboratory Informatics for Diagnostics (LIS/Middleware/Analyzer Connectivity)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAJ
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Clinical Diagnostics Quality Control Materials
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Quality Control Materials
TypeOne Time License
Description

Sale of Multichem third-party quality control materials for clinical chemistry, immunoassay, cardiac, infectious disease, immunology, urine chemistry, diabetes, fertility, immunosuppressant, coagulation, mass spectrometry, and COVID-19 testing applications. Products are sold in frozen liquid stable formats as ready-to-use vials.

technopathclinicaldiagnostics.com:443
2IAMQC Software Solutions
TypeSubscription Recurring
Description

Subscription-based access to IAMQC Peer and IAMQC Infinity informatics platforms providing automated QC monitoring, peer comparison reporting, and XML configuration capabilities for laboratory quality management.

technopathclinicaldiagnostics.com:443
3IVD Raw Materials
TypeOne Time License
Description

Supply of in vitro diagnostic raw materials to IVD manufacturers.

technopathclinicaldiagnostics.com:443
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Multichem
Description

Third party quality control materials brand covering cardiac, COVID-19, immunoassay, clinical chemistry, infectious diseases, immunology, urine chemistry, diabetes, fertility, immunosuppressant, coagulation, barcoded QC solutions, and mass spectrometry.

technopathclinicaldiagnostics.com:443
+1 more record
Core offering1 text field

Technopath develops and manufactures Multichem third-party quality control materials in frozen liquid-stable, ready-to-use formats spanning cardiac, COVID-19, immunoassay, clinical chemistry, infectious disease, immunology, urine chemistry, diabetes, fertility, immunosuppressant, coagulation, mass spectrometry, and barcoded QC applications for clinical laboratories. The company complements these materials with IAMQC informatics software (IAMQC Peer and IAMQC Infinity) for automated QC monitoring, peer comparison reporting, and onboard integration with Abbott Alinity ci analyzers, and supplies IVD raw materials to instrument manufacturers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Important savings in terms of time and costs compared to non-consolidated QC materials
+2 more records
Product overview1 text field

Technopath Clinical Diagnostics is a leading global developer and manufacturer of quality control (QC) materials and software solutions for clinical laboratories. The product portfolio comprises two core offerings: (1) Multichem® Third Party Quality Control Materials — a comprehensive suite of frozen liquid stable, ready-to-use QC materials spanning cardiac markers (including Multichem hsTn), COVID-19, immunoassay, clinical chemistry, infectious diseases, immunology, urine chemistry, diabetes, fertility (Multichem AMH), immunosuppressant drugs, coagulation (Multichem D-Dimer), barcoded solutions, and mass spectrometry; and (2) IAMQC® Informatics Solutions — software products including IAMQC Peer for peer comparison reporting and IAMQC Infinity for next-generation QC data management. Technopath also offers IVD Raw Materials and holds Abbott approval as an onboard third-party QC provider for Abbott Alinity ci systems.

Product and service19 records
1Multichem Third Party Quality Control Materials
CategoryQuality Control Materials
Description

Comprehensive suite of third-party quality control materials in frozen liquid-stable, ready-to-use formats for clinical laboratories performing routine and specialty diagnostic testing across multiple instrument platforms.

2Multichem hsTn (High Sensitive Troponin)
CategoryQuality Control Materials
Description

Third-party high-sensitive troponin QC in frozen liquid-stable format for cardiac biomarker testing in clinical laboratories.

3Multichem COVID-19
CategoryQuality Control Materials
Description

Quality control material for COVID-19 diagnostic testing in clinical laboratories.

4Multichem Immunoassay
CategoryQuality Control Materials
Description

Quality control material for immunoassay testing on clinical chemistry analyzers.

5Multichem Clinical Chemistry
CategoryQuality Control Materials
Description

Quality control material for clinical chemistry analyzer testing in clinical laboratories.

6Multichem Cardiac
CategoryQuality Control Materials
Description

Quality control material for cardiac testing including troponin and other cardiac biomarkers.

7Multichem Infectious Disease
CategoryQuality Control Materials
Description

Quality control material for infectious disease testing in clinical laboratories.

8Multichem Immunology
CategoryQuality Control Materials
Description

Quality control material for immunology testing in clinical laboratories.

9Multichem Urine Chemistry
CategoryQuality Control Materials
Description

Quality control material for urine chemistry analysis in clinical laboratories.

10Multichem Diabetes
CategoryQuality Control Materials
Description

Quality control material for diabetes testing in clinical laboratories.

11Multichem AMH (Fertility)
CategoryQuality Control Materials
Description

Quality control material for Anti-Mullerian Hormone (AMH) fertility testing in clinical laboratories.

12Multichem Immunosuppressant
CategoryQuality Control Materials
Description

Quality control material for immunosuppressant drug monitoring in clinical laboratories.

13Multichem D-Dimer (Coagulation)
CategoryQuality Control Materials
Description

Quality control material for D-Dimer coagulation testing in clinical laboratories.

14Multichem Barcoded QC Solutions
CategoryQuality Control Materials
Description

Barcoded quality control solutions for automated tracking and management in laboratory settings.

15Multichem Mass Spectrometry
CategoryQuality Control Materials
Description

Quality control material for mass spectrometry applications in clinical laboratories.

16Multichem Abbott Alinity QC
CategoryQuality Control Materials
Description

Automated quality control product for Abbott Alinity ci systems, enabling onboard third-party QC directly on the analyzer. Technopath is the only Abbott-approved onboard third-party QC provider for Alinity ci systems.

17IAMQC Peer
CategoryLaboratory Informatics Software
Description

Peer-comparison software that enables laboratories to compare QC results with other laboratories using the same instruments and methods.

18IAMQC Infinity
CategoryLaboratory Informatics Software
Description

Next-generation QC informatics solution for automated quality control monitoring, reporting, and laboratory quality management.

19IVD Raw Materials
CategoryIVD Raw Materials
Description

Raw materials supplied to in vitro diagnostic (IVD) manufacturers for use in diagnostic test production.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Abbott Diagnostics Division
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2012-01-01
Description

Global product development, supply and distribution agreement signed in 2012. Abbott distributes Technopath's third-party quality controls worldwide. Technopath is the only Abbott-approved onboard third party QC provider for Alinity ci systems. The partnership enables Abbott to offer market-leading third-party QC options to its global customer base.

technopathclinicaldiagnostics.com:443
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Technopath is part of LGC Clinical Diagnostics. LGC acquired Technopath Clinical Diagnostics to strengthen its position in clinical quality controls. LGC is listed on the London Stock Exchange.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Established collaboration in 2017. Northwell Health, New York's largest healthcare provider with over 30 million tests annually, converted to Technopath QC solutions. Northwell provides customer testimonials and case study reference for Technopath.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Technopath Clinical Diagnostics

Clinical Diagnostics Quality Control Materialstechnopathclinicaldiagnostics.com

Technopath Clinical Diagnostics, an Ireland-based LGC Group subsidiary, develops and manufactures Multichem third-party quality control materials and IAMQC informatics software for clinical laboratories worldwide, distributed globally through Abbott Diagnostics.

What Technopath Clinical Diagnostics does

Technopath Clinical Diagnostics is an Ireland-based developer and manufacturer of third-party quality control (QC) materials and informatics software for clinical laboratories, operating as a subsidiary of LGC Clinical Diagnostics within the London-listed LGC Group. The company's core technology comprises Multichem® QC materials in a proprietary frozen liquid stable, ready-to-use vial format spanning clinical chemistry, immunoassay, cardiac markers (including High Sensitive Troponin), infectious disease, immunology, urine chemistry, diabetes, fertility, immunosuppressant drugs, coagulation, mass spectrometry, and COVID-19 testing applications. Its IAMQC® software platform — including IAMQC Peer for cross-laboratory peer comparison reporting and IAMQC Infinity for next-generation QC data management — provides subscription-based automated quality control monitoring and reporting.

The company serves hospital laboratories, reference laboratories, and commercial clinical testing facilities globally, with reference customers including Northwell Health (USA), PathCare (South Africa), and Ramon y Cajal Hospital (Spain). Technopath generates revenue through three streams: consumable QC material sales (recurring volume), IAMQC software subscriptions, and IVD raw materials supply to IVD manufacturers. Its go-to-market combines enterprise field sales targeting major laboratories and healthcare systems with a global distribution partnership with Abbott Diagnostics Division established in 2012, under which Technopath holds exclusive status as the only Abbott-approved onboard third-party QC provider for Alinity ci systems. Products meet CLIA, CLSI, CAP, RiliBÄK, and ISO accreditation requirements, addressing regulatory compliance, cost efficiency, and automated monitoring pain points for clinical laboratories.

Technopath Clinical Diagnostics firmographics

Firmographics
Name
Technopath Clinical Diagnostics
Legal name
Technopath Clinical Diagnostics
Website
https://technopathclinicaldiagnostics.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
51–100 employees
Short description
Technopath Clinical Diagnostics, an Ireland-based LGC Group subsidiary, develops and manufactures Multichem third-party quality control materials and IAMQC informatics software for clinical laboratories worldwide, distributed globally through Abbott Diagnostics.
Ownership category
akta.pro rank

Technopath Clinical Diagnostics industry classification

Industry
Product category
Clinical Diagnostics Quality Control Materials
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAAAL
Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHAAAO
Laboratory Informatics for Diagnostics (LIS/Middleware/Analyzer Connectivity)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAJ
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)

Keywords

  • Clinical quality controls
  • Third party QC materials
  • Laboratory informatics software
  • In vitro diagnostics controls
  • Immunoassay quality controls

Where Technopath Clinical Diagnostics is headquartered

Location

Headquarters

HQ city
Ballina
HQ country
Ireland
HQ region
Europe

Offices1 record

Markets served

Technopath Clinical Diagnostics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Quality Control Materials: Sale of Multichem third-party quality control materials for clinical chemistry, immunoassay, cardiac, infectious disease, immunology, urine chemistry, diabetes, fertility, immunosuppressant, coagulation, mass spectrometry, and COVID-19 testing applications. Products are sold in frozen liquid stable formats as ready-to-use vials.
  2. IAMQC Software Solutions: Subscription-based access to IAMQC Peer and IAMQC Infinity informatics platforms providing automated QC monitoring, peer comparison reporting, and XML configuration capabilities for laboratory quality management.
  3. IVD Raw Materials: Supply of in vitro diagnostic raw materials to IVD manufacturers.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Technopath Clinical Diagnostics product offering

Product offering

Core offering

Technopath develops and manufactures Multichem third-party quality control materials in frozen liquid-stable, ready-to-use formats spanning cardiac, COVID-19, immunoassay, clinical chemistry, infectious disease, immunology, urine chemistry, diabetes, fertility, immunosuppressant, coagulation, mass spectrometry, and barcoded QC applications for clinical laboratories. The company complements these materials with IAMQC informatics software (IAMQC Peer and IAMQC Infinity) for automated QC monitoring, peer comparison reporting, and onboard integration with Abbott Alinity ci analyzers, and supplies IVD raw materials to instrument manufacturers.

Product overview

Technopath Clinical Diagnostics is a leading global developer and manufacturer of quality control (QC) materials and software solutions for clinical laboratories. The product portfolio comprises two core offerings: (1) Multichem® Third Party Quality Control Materials — a comprehensive suite of frozen liquid stable, ready-to-use QC materials spanning cardiac markers (including Multichem hsTn), COVID-19, immunoassay, clinical chemistry, infectious diseases, immunology, urine chemistry, diabetes, fertility (Multichem AMH), immunosuppressant drugs, coagulation (Multichem D-Dimer), barcoded solutions, and mass spectrometry; and (2) IAMQC® Informatics Solutions — software products including IAMQC Peer for peer comparison reporting and IAMQC Infinity for next-generation QC data management. Technopath also offers IVD Raw Materials and holds Abbott approval as an onboard third-party QC provider for Abbott Alinity ci systems.

Differentiator

Problem solved

Functional benefit

Brands

  • Multichem: Third party quality control materials brand covering cardiac, COVID-19, immunoassay, clinical chemistry, infectious diseases, immunology, urine chemistry, diabetes, fertility, immunosuppressant, coagulation, barcoded QC solutions, and mass spectrometry.
  • IAMQC

Products and services

  • Multichem Third Party Quality Control Materials Comprehensive suite of third-party quality control materials in frozen liquid-stable, ready-to-use formats for clinical laboratories performing routine and specialty diagnostic testing across multiple instrument platforms.
  • Multichem hsTn (High Sensitive Troponin) Third-party high-sensitive troponin QC in frozen liquid-stable format for cardiac biomarker testing in clinical laboratories.
  • Multichem COVID-19 Quality control material for COVID-19 diagnostic testing in clinical laboratories.
  • Multichem Immunoassay Quality control material for immunoassay testing on clinical chemistry analyzers.
  • Multichem Clinical Chemistry Quality control material for clinical chemistry analyzer testing in clinical laboratories.
  • Multichem Cardiac Quality control material for cardiac testing including troponin and other cardiac biomarkers.
  • Multichem Infectious Disease Quality control material for infectious disease testing in clinical laboratories.
  • Multichem Immunology Quality control material for immunology testing in clinical laboratories.
  • Multichem Urine Chemistry Quality control material for urine chemistry analysis in clinical laboratories.
  • Multichem Diabetes Quality control material for diabetes testing in clinical laboratories.
  • Multichem AMH (Fertility) Quality control material for Anti-Mullerian Hormone (AMH) fertility testing in clinical laboratories.
  • Multichem Immunosuppressant Quality control material for immunosuppressant drug monitoring in clinical laboratories.
  • Multichem D-Dimer (Coagulation) Quality control material for D-Dimer coagulation testing in clinical laboratories.
  • Multichem Barcoded QC Solutions Barcoded quality control solutions for automated tracking and management in laboratory settings.
  • Multichem Mass Spectrometry Quality control material for mass spectrometry applications in clinical laboratories.
  • Multichem Abbott Alinity QC Automated quality control product for Abbott Alinity ci systems, enabling onboard third-party QC directly on the analyzer. Technopath is the only Abbott-approved onboard third-party QC provider for Alinity ci systems.
  • IAMQC Peer Peer-comparison software that enables laboratories to compare QC results with other laboratories using the same instruments and methods.
  • IAMQC Infinity Next-generation QC informatics solution for automated quality control monitoring, reporting, and laboratory quality management.
  • IVD Raw Materials Raw materials supplied to in vitro diagnostic (IVD) manufacturers for use in diagnostic test production.

Quantifiable outcome

  • Important savings in terms of time and costs compared to non-consolidated QC materials
  • +2 more outcomes

Companies that use Technopath Clinical Diagnostics

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technopath Clinical Diagnostics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Technopath Clinical Diagnostics partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and flagship.

  • Abbott Diagnostics DivisioncoreChannel Partner/ Reseller/ Distributor · 1 January 2012Global product development, supply and distribution agreement signed in 2012. Abbott distributes Technopath's third-party quality controls worldwide. Technopath is the only Abbott-approved onboard third party QC provider for Alinity ci systems. The partnership enables Abbott to offer market-leading third-party QC options to its global customer base.
  • LGC Clinical DiagnosticsflagshipStrategic or Co-development PartnerTechnopath is part of LGC Clinical Diagnostics. LGC acquired Technopath Clinical Diagnostics to strengthen its position in clinical quality controls. LGC is listed on the London Stock Exchange.
  • Northwell HealthcoreStrategic or Co-development PartnerEstablished collaboration in 2017. Northwell Health, New York's largest healthcare provider with over 30 million tests annually, converted to Technopath QC solutions. Northwell provides customer testimonials and case study reference for Technopath.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Technopath Clinical Diagnostics competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Technopath Clinical Diagnostics social profiles

Digital presence

Technopath Clinical Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Technopath Clinical Diagnostics leadership team

Management profile

Number of profiles

Technopath Clinical Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Technopath Clinical Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Technopath Clinical Diagnostics

What does Technopath Clinical Diagnostics do?

Technopath develops and manufactures Multichem third-party quality control materials in frozen liquid-stable, ready-to-use formats spanning cardiac, COVID-19, immunoassay, clinical chemistry, infectious disease, immunology, urine chemistry, diabetes, fertility, immunosuppressant, coagulation, mass spectrometry, and barcoded QC applications for clinical laboratories. The company complements these materials with IAMQC informatics software (IAMQC Peer and IAMQC Infinity) for automated QC monitoring, peer comparison reporting, and onboard integration with Abbott Alinity ci analyzers, and supplies IVD raw materials to instrument manufacturers.

Is Technopath Clinical Diagnostics a public or private company?

Technopath Clinical Diagnostics is a private company. It is classified as corporate owned and is currently operating.

When was Technopath Clinical Diagnostics founded?

Technopath Clinical Diagnostics was founded in 2004. It employs 51 to 100 people.

Where is Technopath Clinical Diagnostics based?

Technopath Clinical Diagnostics is headquartered in Ballina, Ireland, in the Europe region.

How does Technopath Clinical Diagnostics make money?

Three revenue lines are on record. Quality Control Materials are the primary driver. The others are IAMQC Software Solutions and IVD Raw Materials.

Does Technopath Clinical Diagnostics have an API?

No public API is recorded for Technopath Clinical Diagnostics.

What industry is Technopath Clinical Diagnostics in?

Technopath Clinical Diagnostics's product category is Clinical Diagnostics Quality Control Materials. Its primary akta.pro industry code is HLAHAAAL, Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables), with a secondary code of HLAHAAAO, Laboratory Informatics for Diagnostics (LIS/Middleware/Analyzer Connectivity). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireTechnopath Clinical Diagnostics Introduces the First Unified, Purpose-Built Quality-Control (QC) Platform Providing a Higher Level of Confidence in the Precision and Accuracy of Patient Sample ResultsTechnopath Clinical Diagnostics has introduced IAMQC Infinity, a unified Software-as-a-Service platform designed to manage quality control and proficiency testing data for clinical laboratories. The platform consolidates peer comparisons, advanced analytics, and daily QC management into a single system to improve operational efficiency and result accuracy. It is currently rolling out in two phases, with Phase 1 live and Phase 2 scheduled for Q2 2021.PR NewswireTechnopath presenta la primera plataforma unificada de control de calidad (QC)Technopath Clinical Diagnostics launched IAMQC Infinity, a unified software-as-a-service platform designed to streamline quality control processes for clinical laboratories. The platform integrates peer comparison, internal QC analytics, and expert decision-support tools to reduce false positives and operational costs while improving result accuracy. Northwell Hospital is among the initial clients supporting the deployment of this technology.PR NewswireTechnopath présente la première plate-forme unifiée de contrôle de qualité (CQ) spécialisé pour une plus grande fiabilité dans la précision et l'exactitude des résultats des échantillons des patientsTechnopath, a global provider of SaaS-based QC data management solutions, launched IAMQC Infinity, a unified quality control platform for clinical laboratories that consolidates real-time international clinical comparisons, advanced QC analysis tools, proficiency testing data, and daily QC data management into a single cloud-based system. The platform features three tools — IAMQC Peer, IAMQC Daily, and IAMQC Expert — designed to reduce false positive indicators and help laboratory staff make informed QC decisions more efficiently. The international rollout will occur in two phases, with the first phase already live and the second phase, including integrated clinical comparison functionality, expected in Q2 2021.PR NewswireTechnopath Clinical Diagnostics lança a primeira iniciativa sem fins lucrativos de testes para anticorpos da COVID-19 para apoiar as empresas da IrlandaTechnopath Clinical Diagnostics announced on June 2, 2020, the launch of a non-profit COVID-19 antibody testing initiative in Ireland to help businesses safely return employees to workplaces. The company is partnering with Corporate Health Ireland and using testing platforms from Abbott Diagnostics and Roche Diagnostics to provide professional blood sample collection and confidential results. The initiative aims to support Irish businesses during the pandemic while also enabling antibody-positive individuals to potentially donate plasma for therapeutic use.PR NewswireTechnopath Clinical Diagnostics lanza la primera iniciativa de test de anticuerpos COVID-19 en IrlandaTechnopath Clinical Diagnostics announced the launch of COVID-19 antibody testing services in Ireland on a non-profit basis to help businesses safely return employees to work. The initiative uses Abbott Diagnostics and Roche Diagnostics testing platforms and has partnered with Corporate Health Ireland for professional blood sample collection, with plans to expand to additional occupational health providers in a second phase. The company stated that antibody testing could support reopening Ireland's economy and enable individuals with antibodies to donate plasma for therapeutic use.PR NewswireTechnopath Clinical Diagnostics startet die erste nicht gewinnorientierte COVID-19-Antikörpertestinitiative zur Unterstützung von Unternehmen in IrlandTechnopath Clinical Diagnostics announced the launch of a not-for-profit COVID-19 antibody testing initiative in Ireland to help businesses safely return employees to the workplace, utilizing testing platforms from Abbott Diagnostics and Roche Diagnostics. The company is partnering initially with Corporate Health Ireland for professional blood sample collection and results reporting, with plans to expand to additional occupational health providers in a second phase. Individuals who test positive for antibodies will also have the option to donate plasma for therapeutic purposes to aid recovery of severely ill COVID-19 patients.PR NewswireTechnopath Clinical Diagnostics lance la première initiative à but non lucratif de tests d'anticorps de la COVID-19 pour aider les entreprises en IrlandeTechnopath Clinical Diagnostics launched a non-profit COVID-19 antibody testing initiative in Ireland to help businesses safely reopen workplaces. The company is providing tests using Abbott and Roche platforms through a partnership with Corporate Health Ireland, aiming to facilitate economic recovery by ensuring employee safety.PR NewswireTechnopath Clinical Diagnostics lanza la primera iniciativa sin fines de lucro de evaluación de anticuerpos para el COVID-19 en apoyo a compañías de IrlandaTechnopath Clinical Diagnostics announced the launch of a non-profit COVID-19 antibody testing initiative in Ireland to help companies safely return employees to workplaces. The company is partnering with Corporate Health Ireland for the first phase, using testing platforms from Abbott Diagnostics and Roche Diagnostics, with plans to expand testing availability to workplaces across the country. The initiative also aims to enable antibody-positive individuals to donate plasma for therapeutic use in treating severe COVID-19 cases.PR NewswireTechnopath Clinical Diagnostics Launches the First Not-For-Profit COVID-19 Antibody Testing Initiative to Support Companies in IrelandTechnopath Clinical Diagnostics announced the launch of a not-for-profit COVID-19 antibody testing initiative in Ireland to support businesses in safely returning employees to work. The company is partnering with Corporate Health Ireland to provide professional blood sample collection and testing using Abbott Diagnostics and Roche Diagnostics platforms. Phase Two will explore expanding partnerships with additional occupational health providers across Ireland to make testing more widely available at workplaces.